- Previous Close
0.1850 - Open
0.1750 - Bid 0.1800 x --
- Ask 0.2350 x --
- Day's Range
0.1750 - 0.1850 - 52 Week Range
0.0500 - 0.2500 - Volume
7,500 - Avg. Volume
17,957 - Market Cap (intraday)
1.595M - Beta (5Y Monthly) 1.05
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date Mar 24, 2025 - Mar 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Entheon Biomedical Corp. operates as a biotechnology research and development company. It engages in developing of products for treating addiction and substance use disorders. The company is headquartered in Vancouver, Canada.
www.entheonbiomedical.comRecent News: ENBI.CN
View MorePerformance Overview: ENBI.CN
Trailing total returns as of 1/3/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ENBI.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ENBI.CN
View MoreValuation Measures
Market Cap
1.59M
Enterprise Value
1.37M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.53
Price/Book (mrq)
6.96
Enterprise Value/Revenue
4.88
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-59.42%
Return on Equity (ttm)
-99.51%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-307.69k
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
228.6k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-200.09k